Cart
sales@molnova.com
Home - Products - Others - Other Targets - (15alpha,20Z)-15-hydroxy-3,11,23-trioxo-Lanosta-8,20(22)-dien-26-oic acid

(15alpha,20Z)-15-hydroxy-3,11,23-trioxo-Lanosta-8,20(22)-dien-26-oic acid

CAS No. 1961358-01-9

(15alpha,20Z)-15-hydroxy-3,11,23-trioxo-Lanosta-8,20(22)-dien-26-oic acid( —— )

Catalog No. M32249 CAS No. 1961358-01-9

15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid is a Lanostane triterpenoid compound with the ability to inhibit NO production in LPS-induced microglia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    (15alpha,20Z)-15-hydroxy-3,11,23-trioxo-Lanosta-8,20(22)-dien-26-oic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid is a Lanostane triterpenoid compound with the ability to inhibit NO production in LPS-induced microglia.
  • Description
    15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid is a Lanostane triterpenoid compound with the ability to inhibit NO production in LPS-induced microglia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1961358-01-9
  • Formula Weight
    498.66
  • Molecular Formula
    C30H42O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • GSK2879552 dihydroch...

    GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.

  • Robtin

    Robtin

  • Picrasidine I

    Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.

Sign In Join Free